Growing evidence supports the existence of an intermediate metastatic disease state.
Michael Smigelski, MD
Advertisement
Smigelski is a chief resident at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Articles by Michael Smigelski, MD
Advertisement
Latest Updated Articles
Management of hormone-naïve oligometastatic prostate cancerPublished: November 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
